BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2476601, FOXP1, cell-cell adhesion, Inflammatory disorder, Hypothalamus)
Bookmark Forward

QuickView for dicoumarol (compound)


Genetic Markers

Most Correlated Genes

  1. FGF9
  2. VKORC1
  3. SPP2
  4. ARG1
  5. EGR1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. response to organic substance
  2. organic cyclic compound binding
  3. heterocyclic compound binding
  4. PILON_KLF1_TARGETS_DN
  5. identical protein binding
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
  2. Drug target sets for approved compounds
  3. Broad Connectivity Map (CMAP 2.0) compound database
  4. Liver Pharmacology and Xenobiotic Response Repertoire
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Comprehensive Evaluation of an HPLC-MS-MS Method for Quantitation of Seven Anti-Coagulant Rodenticid…
  2. Sustained Release of Dicumarol via Novel Grafted Polymer in Electrospun Nanofiber Membrane for Treat…
  3. A pharmacological review of dicoumarol: An old natural anticoagulant agent.
  4. Binding of dicoumarol analog with DNA and its antioxidant studies: A biophysical insight by in-vitro…
  5. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study Confirms or Refutes the Hypothesis That the Autologous Bone Marrow Concentrate Together With t…
  2. DeFRA Questionnaire as an Anamnestic Form
  3. Genotype-guided Versus Standard for Warfarin Dosing
  4. The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients
  5. Evaluation of Efficacy and Safety of Gynomax® XL Ovule
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.